Oxbryta Receives FDA Approval for Trea... - Sickle Cell Society

Sickle Cell Society

1,898 members504 posts

Oxbryta Receives FDA Approval for Treating Sickle Cell Disease

RobertReny
RobertReny

On Monday, the U.S. Food and Drug Administration (FDA) announced accelerated approval of Oxbryta (voxelotor) for the treatment of sickle cell disease in patients aged 12 and above.

“Oxbryta is the first approved treatment for sickle cell disease that directly inhibits the root cause of the disease, sickle hemoglobin polymerization.”

Human trials were conducted on 274 patients with sickle cell disease, of which, 90 patients were given 1,500 mg Oxbryta, 92 patients were given 900 mg, while the remaining 92 patients were given a placebo.

After 24 weeks, more than 51 percent of patients who received Oxbryta 1,500 mg had a greater hemoglobin response when compared with only 6.5 percent of patients who were given a placebo.

Source:- bit.ly/35ICsWB

10 Replies

Hello Robert will Oxbryta, in time become available in the UK, specifically on the NHS.

RobertReny
RobertReny in reply to baba360

As if for now I don't have any update.

When will it be available in Nigeria. Thank you Jesus and holyspirit

RobertReny
RobertReny in reply to Chibaby1

As if for now I don't have any update.

Drivee
Drivee in reply to Chibaby1

Hello, have you by any chance gotten the drug now? I live in Nigeria too

When will this be in Nigeria, and what range can the price be?

RobertReny
RobertReny in reply to Drivee

Not sure about the exact price, a lot of time and effort are put on this medicine. I don't think it is going to be affordable.

Drivee
Drivee in reply to RobertReny

One more problem for the average sickler

I read an article online that it would be around $100,000 for a one year treatment and one has to take it for a lifetime. It is relatively expensive and that would be an issue on it's own.

Drivee
Drivee in reply to arinzemuo21

Absolutely. It's a solution that births another entirely new problem!!!

You may also like...